glp 1 agonist liraglutide FDA Approves First Generic Once-Daily Injection GLP-1 Benefits: Benefits of GLP-1

Each pathway targets specific aspects of vascular and cellular integrity, contributing to the overall protection and remodeling of the retinal vasculature in conditions like DR and ischemic retinal diseases (see Figure 5)

Challa TD, Beaton N, Arnold M, Rudofsky G, Langhans W, Wolfrum C

adult populationtake glucagon-like peptide-1 receptor agonists (GLP-1RAs) for chronic diseases or weight loss

Summary Retatrutide, a triple agonist now in phase 3 trials, has the potential to become the most effective pharmacological treatment for obesity while also offering substantial benefits in T2D management and other cardiometabolic risk factors

Approach: His work emphasizes evidence-based microbiome science, long-term safety, and a systems-based understanding of how microbes influence human health

doi:10.1016/j.oret.2024.05.003 22